Flemming Saether

Array ( [id] => 16336482 [patent_doc_number] => 10787426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-29 [patent_title] => Method of treating autism spectrum disorders using piperazine-1-carboxamidine or pharmaceutically acceptable salt thereof [patent_app_type] => utility [patent_app_number] => 16/300298 [patent_app_country] => US [patent_app_date] => 2017-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6114 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12283003 [patent_doc_number] => 09931314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Method for treating skin cancer [patent_app_type] => utility [patent_app_number] => 15/590645 [patent_app_country] => US [patent_app_date] => 2017-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6517 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13065403 [patent_doc_number] => 10053474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-21 [patent_title] => Anti-viral compounds [patent_app_type] => utility [patent_app_number] => 15/588037 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33034 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11986669 [patent_doc_number] => 20170290825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-12 [patent_title] => 'PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 15/583412 [patent_app_country] => US [patent_app_date] => 2017-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 13981 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16296174 [patent_doc_number] => 20200281897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => INDAZOLE DERIVATIVES FOR CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 16/097149 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16806 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11828721 [patent_doc_number] => 09725455 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-08-08 [patent_title] => 'Crystalline forms of a bruton\'s tyrosine kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 15/497896 [patent_app_country] => US [patent_app_date] => 2017-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 41573 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15497896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17206598 [patent_doc_number] => 11166949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-09 [patent_title] => NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic [patent_app_type] => utility [patent_app_number] => 16/096536 [patent_app_country] => US [patent_app_date] => 2017-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 14339 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12000078 [patent_doc_number] => 20170304232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'Endoxifen For Local Transdermal Therapy To The Breast' [patent_app_type] => utility [patent_app_number] => 15/492641 [patent_app_country] => US [patent_app_date] => 2017-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28967 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16742012 [patent_doc_number] => 10966981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Fatty acid synthase inhibitors [patent_app_type] => utility [patent_app_number] => 16/094872 [patent_app_country] => US [patent_app_date] => 2017-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16977 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18762882 [patent_doc_number] => 11813261 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-14 [patent_title] => HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic lymphocytic leukemia [patent_app_type] => utility [patent_app_number] => 16/093278 [patent_app_country] => US [patent_app_date] => 2017-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 6 [patent_no_of_words] => 15786 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14210421 [patent_doc_number] => 20190117595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-25 [patent_title] => METHOD FOR TREATING PLEUROPERITONEAL MEMBRANE CANCERS BY LOCALLY INJECTING DISULFIRAM PREPARATION [patent_app_type] => utility [patent_app_number] => 16/093187 [patent_app_country] => US [patent_app_date] => 2017-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15848079 [patent_doc_number] => 10639300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists [patent_app_type] => utility [patent_app_number] => 16/090317 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9805 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15848079 [patent_doc_number] => 10639300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists [patent_app_type] => utility [patent_app_number] => 16/090317 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9805 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15848079 [patent_doc_number] => 10639300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists [patent_app_type] => utility [patent_app_number] => 16/090317 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9805 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15848079 [patent_doc_number] => 10639300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists [patent_app_type] => utility [patent_app_number] => 16/090317 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9805 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11977435 [patent_doc_number] => 20170281589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'USE OF STING AGONISTS TO TREAT CHRONIC HEPATITIS B VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 15/483645 [patent_app_country] => US [patent_app_date] => 2017-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9395 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17266356 [patent_doc_number] => 11191760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-07 [patent_title] => Compositions and methods for treating [patent_app_type] => utility [patent_app_number] => 16/091173 [patent_app_country] => US [patent_app_date] => 2017-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8395 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15360707 [patent_doc_number] => 20200016118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => HDAC INHIBITOR IN COMBINATION WITH VEGF/VEGFR INTERACTION FOR CANCER THERAPY BASED ON PLATELET COUNT [patent_app_type] => utility [patent_app_number] => 15/766197 [patent_app_country] => US [patent_app_date] => 2017-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8350 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12210979 [patent_doc_number] => 09907770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-06 [patent_title] => 'Methods and compositions for increasing the anaerobic working capacity in tissues' [patent_app_type] => utility [patent_app_number] => 15/476620 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 11780 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11977491 [patent_doc_number] => 20170281645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'STEROID HORMONE PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 15/473733 [patent_app_country] => US [patent_app_date] => 2017-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14817 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15473733 [rel_patent_id] =>[rel_patent_doc_number] =>)